Notably, among nine CHDs, CHD7 was overexpressed (Z‐score ≥ 1) in 71.54% of TCGA basal‐like breast cancers, compared to 20.49% of luminal A subtype (P < 0.01; Fig. 2A and Table S5). Here, CHD7 is linked to breast carcinoma.